Sulindac activates NF-κB signaling in colon cancer cells

BACKGROUND: The non-steroidal anti-inflammatory drug (NSAID) sulindac has shown efficacy in preventing colorectal cancer. This potent anti-tumorigenic effect is mediated through multiple cellular pathways but is also accompanied by gastrointestinal side effects, such as colon inflammation. We have r...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Mladenova, Dessislava, Pangon, Laurent, Currey, Nicola, Ng, Irvin, Musgrove, Elizabeth A, Grey, Shane T, Kohonen-Corish, Maija RJ
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2013
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3896984/
https://ncbi.nlm.nih.gov/pubmed/24083678
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1478-811X-11-73
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы